Transition Therapeutics Inc. – Product Pipeline Review – Q1 2011 by GlobalMarketsDirect

VIEWS: 1 PAGES: 56

More Info
									           Transition Therapeutics Inc. – Product Pipeline
                         Review – Q1 2011
                                                                                          Reference Code: GMDHC1273CDB

                                                                                                Publication Date: JUN 2011




Transition Therapeutics Inc. – Product Pipeline Review – Q1 2011                            GMDHC1273CDB / Published JUN 2011

© Global Markets Direct. This report is a licensed product and is not to be photocopied                                Page(1)
Transition Therapeutics Inc. – Product Pipeline Review




Ta b le o f Co n te n ts
Table of Contents                                                                                                                 2
List of Tables                                                                                                                    4
List of Figures                                                                                                                   4
Transition Therapeutics Inc. Snapshot                                                                                             5
    Transition Therapeutics Inc. Overview                                                                                         5
    Key Information                                                                                                               5
    Key Facts                                                                                                                     5
Transition Therapeutics Inc. – Research and Development Overview                                                                  6
    Key Therapeutic Areas                                                                                                         6
Transition Therapeutics Inc. – Pipeline Review                                                                                    9
    Pipeline Products by Stage of Development                                                                                     9
    Pipeline Products – Monotherapy                                                                                              10
Transition Therapeutics Inc. – Pipeline Products Glance                                                                          11
    Transition Therapeutics Inc. Clinical Stage Pipeline Products                                                                11
         Phase I Products/Combination Treatment Modalities                                                                       11
    Transition Therapeutics Inc.–Early Stage Pipeline Products                                                                   12
         Pre-Clinical Products/Combination Treatment Modalities                                                                  12
Transition Therapeutics Inc. – Drug Profiles                                                                                     13
    TT-301                                                                                                                       13
         Product Description                                                                                                     13
         Mechanism of Action                                                                                                     13
         R&D Progress                                                                                                            13
    TT302                                                                                                                        14
         Product Description                                                                                                     14
         Mechanism of Action                                                                                                     14
         R&D Progress                                                                                                            14
    TT401                                                                                                                        15
         Product Description                                                                                                     15
         Mechanism of Action                                                                                                     15
         R&D Progress                                                                                                            15
Transition Therapeutics Inc. – Pipeline Analysis                                                                                 16
    Transition Therapeutics Inc. – Pipeline Products by Therapeutic Class                                                        16
    Transition Therapeutics Inc. - Pipeline Products By Target                                                                   17
    Transition Therapeutics Inc. – Pipeline Products by Route of Administration                                                  18
    Transition Therapeutics Inc. – Pipeline Products by Molecule Type                                                            19
Transition Therapeutics Inc. - Dormant Projects                                                                                  20
Transition Therapeutics Inc. – Locations And Subsidiaries                                                                        21
    Head Office                                                                                                                  21
    Other Locations & Subsidiaries                                                                                               21
Financial Deals Landscape                                                                                                        22
    Transition Therapeutics Inc., Deals Volume Summary, 2004 to YTD 2011                                                         22
    Transition Therapeutics Inc., Deals Summary By Region, 2004 to YTD 2011                                                      23
    Transition Therapeutics Inc., Deals Summary, 2004 to YTD 2011                                                                24
    Transition Therapeutics Inc. Detailed Deal Summary                                                                           25
         Asset Purchase                                                                                                          25
         Transition Therapeutics Acquires Certain Assets And Exclusive Rights From Forbes Medi-Tech                              25




Transition Therapeutics Inc. – Product Pipeline Review – Q1 2011                                      GMDHC1273CDB / Published JUN 2011

©Global Markets Direct.. This report is a licensed product and is not to be photocopied                                         Page(2)
Transition Therapeutics Inc. – Product Pipeline Review



         Transition Therapeutics Acquires Optimol Small-Molecule Drug Discovery Technology And Capital Assets From Protana      27
         Acquisition                                                                                                            29
         Transition Therapeutics Acquires NeuroMedix                                                                            29
         Transition Therapeutics Acquires Ellipsis Neurotherapeutics                                                            31
         Transition Therapeutics Acquires Minority Stake In Ellipsis Neurotherapeutics                                          33
         Neurogenesis Acquires Stem Cell Therapeutics                                                                           35
         Equity Offering                                                                                                        37
         Transition Therapeutics Completes Private Placement of $24 Million                                                     37
         Transition Therapeutics Completes Private Placement Of $22 Million                                                     39
         Transition Therapeutics Completes Private Placement Of $9 Million                                                      41
         Transition Therapeutics Completes Private Placement Of $4.4 Million                                                    43
         Eli Lilly Enters Into Agreement With Transition Therapeutics                                                           45
         Elan Enters Into Co-Development Agreement With Transition Therapeutics                                                 46
         Transition Therapeutics Enters Into Co-Development Agreement With Juvenile Diabetes Research                           47
         Licensing Agreements                                                                                                   49
         Transition Therapeutics Amends Licensing Agreement With Novo Nordisk                                                   49
         Transition Therapeutics Enters Into Licensing Agreement With London Health Sciences Centre Research                    51
         Transition Therapeutics Enters Into An Agreement With Novo Nordisk                                                     52
         Transition Therapeutics Terminates License Agreement With Novo Nordisk                                                 54
Appendix                                          
								
To top